CLPT Earnings ClearPoint Neuro, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–28 of 28
| Q2 2026 | 2026-06-30 | -0.70 | 2026-08-03 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.32 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -0.90 | 2026-03-17 | 10-K |
| Q3 2025 | 2025-09-30 | -0.63 | 2025-11-06 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.42 | 2026-08-03 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.22 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -0.70 | 2026-03-17 | 10-K |
| Q3 2025 | 2024-09-30 | -0.50 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.32 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.16 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -0.90 | 2025-02-26 | 10-K |
| Q3 2024 | 2023-09-30 | -0.71 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.52 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.23 | 2024-05-07 | 10-Q |
| FY 2023 | 2022-12-31 | -0.68 | 2024-03-12 | 10-K |
| Q3 2023 | 2022-09-30 | -0.50 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.35 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.17 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -0.69 | 2023-03-01 | 10-K |
| Q3 2022 | 2021-09-30 | -0.50 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.31 | 2022-08-10 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.13 | 2022-05-11 | 10-Q |
| Q2 2015 | 2015-06-30 | -0.12 | 2015-08-10 | 10-Q |
| Q1 2015 | 2015-03-31 | -0.05 | 2015-05-07 | 10-Q |
| Q2 2015 | 2014-06-30 | 0.02 | 2015-08-10 | 10-Q |
| Q1 2015 | 2014-03-31 | 0.04 | 2015-05-07 | 10-Q |
| Q2 2014 | 2013-06-30 | -0.04 | 2014-08-11 | 10-Q |
| Q1 2014 | 2013-03-31 | -0.02 | 2014-05-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.